Skip to main content

Rafferty Asset Management, LLC

SEC CIK
0001389426
Latest filing
Aug 14, 2026

ITOS holding history

iTeos Therapeutics, Inc. in every 13F filed by Rafferty Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITOS overviewAll 13F holders of ITOSFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q1 2021
Holdings of ITOS by Rafferty Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−49,835−100.0%Sold outHolders
Q3 202449,835$508.8K<0.1%+13,850+38.5%AddedHolders
Q2 202435,985$534.0K<0.1%+35,985NewHolders
Q4 20230$00.0%−85,189−100.0%Sold outHolders
Q3 202385,189$932.8K<0.1%−1,409−1.6%ReducedHolders
Q2 202386,598$1.15M<0.1%−27,452−24.1%ReducedHolders
Q1 2023114,050$1.55M<0.1%+11,384+11.1%AddedHolders
Q4 2022102,666$2.01M<0.1%−23,435−18.6%ReducedHolders
Q3 2022126,101$2.40M<0.1%+26,733+26.9%AddedHolders
Q2 202299,368$2.05M<0.1%+2,067+2.1%AddedHolders
Q1 202297,301$3.13M<0.1%+56,985+141.3%AddedHolders
Q4 202140,316$1.88M<0.1%+40,316NewHolders
Q2 20210$00.0%−27,221−100.0%Sold outHolders
Q1 202127,221$930.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.